Apellis's Empaveli is the first drug to reach the IC-MPGN market and will compete against Novartis' Fabhalta in C3G, another rare kidney disease.

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited condition that can lead to kidney failure. Being able to accurately predict how the disease will progress is very ...

Certain urine biomarkers may noninvasively assess kidney health in patients with diabetic kidney disease and help identify risk for chronic kidney disease progression, according to study data ...

What did we find? We found 27 studies involving over 5410 people with kidney disease that looked at the benefits and complications of different anaemia treatments, comparing the newer anaemia ...

With investors and drugmakers increasingly eyeing the kidney disease space, a new company hopes to shed its underdog status to create treatments for a hard-to-treat condition.

Using CRISPR to correct the mutations behind polycystic kidney disease could counter some of the damage the condition causes ...

As cases of chronic kidney disease emerge in outdoor laborers around the world, scientists are finding that repeated damage from prolonged extreme heat seems to be a leading factor to kidney failure ...

Otsuka has shared data behind its kidney disease drug’s win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio levels.

Explore the genetics, clinical guidelines, and future research shaping the treatment of Polycystic Kidney Disease (PKD).

Proper oral and dental care is an essential part of managing chronic kidney disease. Learn more about the link and what experts recommend for dental care.

Initiating chronic kidney disease (CKD) screening at age 55 yielded substantial reductions in kidney failure incidence and improvements in life expectancy across all groups.

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and symptoms and how it’s diagnosed and treated.